SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share (SLS)

Historical Holders from Q4 2019 to Q3 2025

Symbol
SLS on Nasdaq
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
105,841,018
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
32,917,301
Holdings value
$53,012,951
% of all portfolios
0%
Number of holders
92
Number of buys
49
Number of sells
-25
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share (SLS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 6.7% $14,661,610 6,694,799 The Vanguard Group 30 Jun 2025
Anson Funds Management LP 5.7% +16% $9,713,030 +$1,299,254 6,032,938 +15.4% Anson Funds Management LP 30 Sep 2025
BlackRock, Inc. 5.4% $9,155,886 5,686,886 BlackRock, Inc. 30 Sep 2025

Institutional Holders of SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share (SLS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 32,917,301 $53,012,951 +$9,796,863 $1.61 92
2025 Q2 26,771,579 $58,629,839 +$27,498,028 $2.19 78
2025 Q1 14,287,843 $15,431,614 +$8,743,246 $1.08 43
2024 Q4 6,195,241 $6,443,955 +$751,049 $1.04 29
2024 Q3 5,385,570 $6,729,539 +$1,661,405 $1.25 30
2024 Q2 4,056,846 $4,828,846 -$3,466,325 $1.19 29
2024 Q1 7,717,105 $7,794,727 +$4,207,509 $1.01 27
2023 Q4 3,493,044 $3,702,505 +$352,826 $1.06 29
2023 Q3 2,751,676 $4,512,830 -$594,241 $1.64 25
2023 Q2 3,114,137 $4,889,035 +$175,383 $1.57 22
2023 Q1 2,996,127 $4,284,993 +$1,438,716 $1.43 20
2022 Q4 1,889,269 $4,456,259 +$91,291 $2.36 27
2022 Q3 2,186,943 $4,418,000 -$1,738,313 $2.02 25
2022 Q2 2,979,307 $6,641,000 +$1,671,317 $2.23 23
2022 Q1 1,688,629 $11,276,000 -$279,247 $6.68 25
2021 Q4 1,733,782 $9,586,000 -$1,340,161 $5.53 26
2021 Q3 1,859,470 $17,100,000 -$844,204 $9.16 29
2021 Q2 1,897,926 $21,282,000 +$4,739,163 $11.1 28
2021 Q1 1,552,743 $13,246,990 +$5,287,808 $8.54 28
2020 Q4 925,075 $5,374,000 +$2,503,596 $5.81 17
2020 Q3 616,674 $1,633,000 +$397,179 $2.65 10
2020 Q2 455,904 $1,335,000 +$144,563 $2.93 12
2020 Q1 415,637 $720,000 -$87,849 $1.74 10
2019 Q4 389,002 $1,672,000 +$1,672,000 $4.3 9